Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
798 Leser
Artikel bewerten:
(2)

Quantiphi Inc: Quantiphi Collaborates with Cerevel Therapeutics to Harness the Power of Google Cloud's AI in Clinical Workflow Management

MARLBOROUGH, Mass., Feb. 6, 2023 /PRNewswire/ -- Quantiphi, an AI-first digital engineering company, today announced that it has entered into a collaboration with Cerevel Therapeutics (Nasdaq: CERE) to harness the power of Google Cloud's Artificial Intelligence (AI) in clinical workflow management, with the goal of improving Cerevel's capabilities to deliver neuroscience solutions to patients as quickly as possible.

With Quantiphi's end-to-end Doc AI solution built on Google Cloud, Cerevel aims to improve the way medical information is processed with greater speed and accuracy. This automated workflow will enable the Company to review, extract and store information from clinical site monitoring reports to flag the review priority. Ultimately, this system reduces manual, time-consuming tasks and allows for complete coverage in a rigorous, consistent and timely manner.

With Doc AI, Cerevel can now process information from trip reports across four templates. The custom-built user interface will allow Cerevel to visualize the status of each action item and decide the best course of action. This system not only reduces manual effort but also fast-tracks the process and clears backlogs.

"Cerevel is committed to executional excellence, and this collaboration and AI solution has given our teams greater insights into reporting across clinical workflows, allowing us to better manage our clinical trials with a focus on quality and compliance. Our teams are excited to add this tool to their arsenal and have already started evaluating additional AI capabilities to further support our mission to push boundaries, develop solutions and transform lives."

Laura Whitmore, Senior Director, Clinical Operations Oversight, Cerevel Therapeutics

"Google Cloud has proven to be a powerful platform for Cerevel as we unravel the mysteries of the brain to treat neuroscience diseases. We have combined Google Cloud's technology, Quantiphi's technical expertise in Artificial Intelligence, and Cerevel's deep domain expertise to accelerate our Cloud and Digital Transformation strategy."

Doug Barta, Chief Information Officer, Cerevel Therapeutics

"At Google Cloud we aim to provide best in class infrastructure to organize the world's data. Across biotechnology firms we have seen this pursuit unlock data sets that were previously unavailable to the scientific teams and investigators. With the application of AI and machine learning technologies to documents, physician notes, electronic medical records and other datasets, we believe companies like Cerevel will be one step closer to a more effective clinical trial environment and gain greater insight into patient care."

Shweta Maniar, Director of Life Sciences Industry Solutions, Google Cloud

"We are delighted to partner with Cerevel and transform the way medical records are processed today. This solution is a step forward towards increasing the accuracy and quality of medical record analysis, reducing the burden on healthcare practitioners and enabling them to precisely target those that need additional attention. This partnership will unlock the transformative power of cloud, data and AI technologies to solve the most pressing problems in the field of neuroscience."

Saurabh Mishra, Practice Leader, Quantiphi

Since AI and Machine Learning (ML) are closely related to data science and statistical prediction, AI will have a large impact on the healthcare system in the future. AI is already involved in simple tasks of answering patient queries, reviewing medical records and analyzing health trends, to more complex clinical and therapeutic decision-making.

The partnership between Quantiphi and Google Cloud has enabled Cerevel to deploy an AI-powered solution to overcome challenges in its day-to-day business. Thus far, the collaboration has shown 99% accuracy in business rule execution and 93% accuracy in entity extraction while saving time and money. This demonstrates that AI-led solutions not only reduce human burden but increase accuracy.

AI goes a long way in augmenting the human decision-making process, and the healthcare and life sciences industry is no exception. The power of AI can be used to create innovative, provocative and hopeful solutions, capable of making the field of medicine and human life better. To know more about how Quantiphi can help augment processes within the healthcare industry, get in touch with our experts.

About Quantiphi

Quantiphi is an award-winning AI-first digital engineering company driven by the desire to reimagine and realize transformational opportunities at the heart of the business. Quantiphi solves the toughest and most complex business problems by combining deep industry experience, disciplined cloud, data-engineering practices, and cutting-edge artificial intelligence research to achieve quantifiable business impact at unprecedented speed.. For more on Quantiphi's capabilities, visit www.quantiphi.com

Media Contact:
Jhon Alexander
(804) 484-9813
jhon.alexander@quantiphi.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/quantiphi-collaborates-with-cerevel-therapeutics-to-harness-the-power-of-google-clouds-ai-in-clinical-workflow-management-301738508.html

© 2023 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.